80 related articles for article (PubMed ID: 3460526)
1. [Autocrine growth factor produced by a human promyelocytic leukemia cell line].
Kasuga M; Yamanouchi T; Asano T; Tsushima T; Takaku F
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1410-5. PubMed ID: 3460526
[TBL] [Abstract][Full Text] [Related]
2. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
3. Purification of a low molecular weight factor that induces differentiation and inhibits growth in myeloid leukemia cells.
Nakaya K; Kumakawa N; Iinuma H; Nakamura Y
Cancer Res; 1988 Aug; 48(15):4201-5. PubMed ID: 3164645
[TBL] [Abstract][Full Text] [Related]
4. Clonal growth of human acute myeloid leukemia cells (ML-1 and HL-60) in serum-free agar medium.
Taketazu F; Kubota K; Kajigaya S; Shionoya S; Motoyoshi K; Saito M; Takaku F; Miura Y
Cancer Res; 1984 Feb; 44(2):531-5. PubMed ID: 6607105
[TBL] [Abstract][Full Text] [Related]
5. Human myelomonocytic cell line THP-1 produces a novel growth-promoting factor with a wide target cell spectrum.
Takeuchi A; Hayashi H; Naito Y; Baba T; Tamatani T; Onozaki K
Cancer Res; 1993 Apr; 53(8):1871-6. PubMed ID: 8467508
[TBL] [Abstract][Full Text] [Related]
6. Effects of conditioned medium upon proliferation, deoxynucleotide metabolism, and antimetabolite sensitivity of promyelocytic leukemic cells in vitro.
Elias L; Wood A; Crissman HA; Ratliff R
Cancer Res; 1985 Dec; 45(12 Pt 1):6301-7. PubMed ID: 3864529
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a cell growth factor from a human leukemia cell line: immunological identity with ferritin.
Kikyo N; Suda M; Kikyo N; Hagiwara K; Yasukawa K; Fujisawa M; Yazaki Y; Okabe T
Cancer Res; 1994 Jan; 54(1):268-71. PubMed ID: 8261451
[TBL] [Abstract][Full Text] [Related]
8. Transferrin as a growth factor for rat bladder carcinoma cells in culture.
Hayashi O; Noguchi S; Oyasu R
Cancer Res; 1987 Sep; 47(17):4560-4. PubMed ID: 3621154
[TBL] [Abstract][Full Text] [Related]
9. Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells.
Buck J; Hämmerling U; Hoffmann MK; Levi E; Welte K
J Immunol; 1987 May; 138(9):2923-8. PubMed ID: 3033079
[TBL] [Abstract][Full Text] [Related]
10. Response of human myeloid leukemia cells to various sources of colony-stimulating activity and phytohemagglutinin-conditioned medium.
Taetle R; Caviles A; Koziol J
Cancer Res; 1983 May; 43(5):2350-7. PubMed ID: 6600965
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
12. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
[TBL] [Abstract][Full Text] [Related]
13. Production by mouse spleen cells of factors stimulating differentiation of mouse myeloid leukemic cells that differ from the colony-stimulating factor.
Yamamoto Y; Tomida M; Hozumi M
Cancer Res; 1980 Dec; 40(12):4804-9. PubMed ID: 6159972
[TBL] [Abstract][Full Text] [Related]
14. Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF.
Yung YP; Eger R; Tertian G; Moore MA
J Immunol; 1981 Aug; 127(2):794-9. PubMed ID: 6788848
[TBL] [Abstract][Full Text] [Related]
15. A novel cell growth-promoting factor identified in a B cell leukemia cell line, BALL-1.
Dao T; Holán V; Minowada J
Neoplasma; 1993; 40(5):265-73. PubMed ID: 8272154
[TBL] [Abstract][Full Text] [Related]
16. Differential cellular retention of vincristine and vinblastine by cultured human promyelocytic leukemia HL-60/Cl cells: the basis of differential toxicity.
Ferguson PJ; Cass CE
Cancer Res; 1985 Nov; 45(11 Pt 1):5480-8. PubMed ID: 3863705
[TBL] [Abstract][Full Text] [Related]
17. Growth factor(s) produced by a human leukemic cell line growing in a protein-free chemically defined medium.
Okabe T; Fujisawa M; Mihara A; Sato S; Fujiyoshi N; Takaku F
Cancer Res; 1986 Mar; 46(3):1043-6. PubMed ID: 3455879
[TBL] [Abstract][Full Text] [Related]
18. Partial purification and initial characterization of a novel differentiation factor for mouse myeloid leukemia cells.
Nakaya K; Kumakawa N; Nakamura Y
Biochem Int; 1985 Apr; 10(4):619-26. PubMed ID: 3861183
[TBL] [Abstract][Full Text] [Related]
19. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
Spens E; Häggström L
Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
[TBL] [Abstract][Full Text] [Related]
20. Purification of a cell growth factor from a human lung cancer cell line: its relationship with ferritin.
Kikyo N; Hagiwara K; Fujisawa M; Kikyo N; Yazaki Y; Okabe T
J Cell Physiol; 1994 Oct; 161(1):106-10. PubMed ID: 7929595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
